alex herrera on nivolumab/brentuximab vedotin combination for patients with hodgkin lymphoma
Published 7 years ago • 275 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:29
dr. herrera on next steps of drug combinations for hodgkin lymphoma
-
2:21
472 consolidation with nivolumab and brentuximab vedotin
-
3:23
brentuximab vedotin, nivolumab, doxorubicin & dacarbazine for early stage classical hodgkin lymphoma
-
9:02
learn about hodgkin lymphoma with dr. alex herrera
-
1:02
dr. hamdan on the potential use of brentuximab vedotin/nivolumab in hodgkin lymphoma
-
5:14
brentuximab vedotin in hodgkin lymphoma
-
2:05
dr. diefenbach on ipilimumab/brentuximab vedotin in patients with rr hodgkin lymphoma
-
0:55
dr. lacasce on treating relapsed/ refractory hodgkin lymphoma with brentuximab vedotin combo
-
2:19
emerging therapeutic options for hodgkin lymphoma
-
9:05
city of hope hematologist/oncologist dr. alex herrera shares symptoms and statistics for blood cance
-
1:36
meet hematologist alex f. herrera, m.d. | city of hope
-
1:21
dr. younes discusses fda approval of nivolumab in hodgkin lymphoma
-
1:21
chep-bv followed by bv consolidation in cd30-expressing ptcl
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
2:14
dr. alex herrera | #ash20
-
9:05
city of hope hematologist/oncologist dr. alex herrera shares symptoms and statistics for blood cance
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
0:53
an update on camidanlumab tesirine in hl
-
1:15
pembrolizumab plus vorinostat in patients with hodgkin lymphoma refractory to prior pd-1 blockade